Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Borderline Resectable Pancreatic Cancer
Interventions
PROCEDURE

Laparoscopic pancreatoduodenectomy

Laparoscopic pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer.

PROCEDURE

Open pancreatoduodenectomy

Open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer.

Trial Locations (1)

200032

RECRUITING

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
collaborator

The Third Affiliated Hospital of Soochow University

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

West China Hospital

OTHER

collaborator

Tongji Hospital

OTHER

collaborator

Fujian Provincial Hospital

OTHER

collaborator

Zhejiang Provincial People's Hospital

OTHER

lead

Fudan University

OTHER